Office of Human Research


  • Director, Office of Human Research
  • Director, Clinical Research Unit
  • Professor, SKMC Department of Pharmacology & Experimental Therapeutics
Contact Number(s):

For Research Activities

  • Senior Associate Provost, Research Integrity, Conduct & Compliance
  • Professor, SKMC Department of Pathology, Anatomy & Cell Biology
Contact Number(s):

COVID-19 Resources

OHR has provided the following resources to assist with changes due to

Changes to Research Made in Response to COVID (PDF) General announcement on changes to clinical research studies due to COVID-19 and how to report them to the IRB.
Changes Made to Study to Eliminate Immediate Apparent Hazard to Research Participants (DOCX) Use this log to document changes made to eliminate immediate hazards to research participants due to COVID-19.  
Guidance for Alternate Routes of Consent in Response to COVID-19 (PDF) A guide to modifying the consent process for compliance with governmental and Jefferson social distancing requirements.
Resuming Non-Essential Clinical Research Operations (RTF)  
Departmental Plan for Resuming Clinical Trials (DOCX)  
Departmental Plan for Resuming Clinical Trials - Excel (XLSX)